Xromi ® (Hydroxycarbamide) 100 mg/ml oral solution

Xromi ® (Hydroxycarbamide) 100 mg/ml oral solution is indicated for:

The prevention of vaso-occlusive complications of Sickle Cell Disease in patients over 2 years of age. 

It is available in the following presentation:

• Xromi ® (Hydroxycarbamide 100 mg/ml

Xromi ® (Hydroxycarbamide) is distributed in Ireland in conjunction with our sister company Medisource in partnership with Nova Laboratories Ireland Limited (This link will take you to a non-Fannin Ltd. website.  Fannin Ltd. does not recommend, endorse or accept liability for sites controlled by third-parties.) 

Method of Sale: POM

License Number: EU/1/19/1366/001

MAH Holder: Nova Laboratories Ireland Limited, 3rd Floor, Ulysses House, Foley Street, Dublin 1, S01 W2T2, Ireland

For any further information please speak to your local Fannin Representative or contact our medical information department for a copy of the SPC at medical@dccvital.com or via phone on 01 2907000

Additional information available on request.

Date of preparation: November 2020

IE2020/033/00